8 weeks of home based use. for Attention Deficit Hyperactivity Disorder (ADHD)
This trial will test how well the Apollo System works in reducing symptoms related to ADHD.
- Attention Deficit Hyperactivity Disorder (ADHD)
3 Primary · 0 Secondary · Reporting Duration: Prior to and following the 8 week study protocol period.
2 Treatment Groups
Commercial Apollo System Device
1 of 2
Sham Apollo System Device
1 of 2
100 Total Participants · 2 Treatment Groups
Primary Treatment: 8 weeks of home based use. · Has Placebo Group · N/A
Who is running the clinical trial?
Age 8 - 17 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||90.9%|
What site did they apply to?
|Department of Kinesiology||100.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||57.1%|
Why did patients apply to this trial?
- "We have tried 3 different medications (adderall, vyvanse and Ritalin) and aren’t seeing the results we have hoped for."
- "I am currently on adderall and want to get off of it but because I have ADHD it's been extremely hard. Ive also been diagnosed with anxiety and depression."
How many prior treatments have patients received?
What questions have other patients asked about this trial?
- "What side effects are there? Does having a diagnosis of ASD effect results?"
Frequently Asked Questions
Are enrollees currently being accepted for this medical trial?
"Affirmative. According to the information uploaded on clinicaltrials.gov, this medical experiment, which was initially advertised on March 18th 2022, is presently enrolling patients. The research team needs to recruit 100 people from a single location." - Anonymous Online Contributor
Is there an opportunity to participate in this medical experiment?
"This medical study is seeking one-hundred candidates between the ages of 8 and 17 that have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). In order to qualify, participants must meet the following criteria: they should be aged at least eight years old and younger than eighteen; have experienced minimal symptom improvement or relief while on a single treatment plan for over twelve months; tried two or more different therapeutic methods without reaching their desired outcome; still in possession of symptoms despite taking medication; endure unwanted side effects due to pharmacological therapy. Moreover, enrollees are required to possess normal vision or corrected visual acuity necessary for completing cognitive tasks" - Anonymous Online Contributor
Does this research have an age-restriction, and if so, what is it?
"This clinical trial only allows participants between the ages of 8 and 17, in line with its pre-set inclusion standards." - Anonymous Online Contributor
To what extent has recruitment for this clinical trial been successful?
"Confirmed. Clinicaltrials.gov has evidence that this medical experiment is actively enrolling patients, which began posting on March 18th 2022 and was most recently updated on the 24th of March. There are 100 participants required in total from a single site." - Anonymous Online Contributor